These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2486483)

  • 21. Carboplatin-based combination chemotherapy for advanced carcinoma of the cervix.
    Junor E; Davies J; Habeshaw T; Kaye S; Paul J; Rankin E; Reed N; Symonds RP
    Cancer Chemother Pharmacol; 1991; 27(6):484-6. PubMed ID: 1707350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
    Vogl SE; Seltzer V; Camacho F; Davis TE
    J Reprod Med; 1986 May; 31(5):327-9. PubMed ID: 2427717
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose bleomycin and methotrexate in cervical cancer.
    Conroy JF; Lewis GC; Brady LW; Brodsky I; Kahn SB; Ross D; Nuss R
    Cancer; 1976 Feb; 37(2):660-4. PubMed ID: 56215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate.
    Aboud A; Buzdar AU; Yap HY; Hortobagyi GN; Blumenschein GR
    J Surg Oncol; 1984 Jul; 26(3):205-7. PubMed ID: 6610802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
    Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
    Buccheri G; Ferrigno D; Rosso A
    Cancer; 1993 Sep; 72(5):1564-72. PubMed ID: 8394198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiblastic treatment of advanced cervical carcinoma and its recurrences: assessment of four different polychemotherapies used for a decade.
    Rigano A; Adamo V; Altavilla G; d'Aquino S
    Eur J Gynaecol Oncol; 1989; 10(4):271-6. PubMed ID: 2476314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study.
    Bacci G; Gherlinzoni F; Picci P; Van Horn JR; Jaffe N; Guerra A; Ruggieri P; Biagini R; Capanna R; Toni A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1337-45. PubMed ID: 3493903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of Adriamycin and mehtotrexate in carcinoma of the cervix. The development of a safe effective regimen.
    Guthrie D; Way S
    Obstet Gynecol; 1978 Sep; 52(3):349-54. PubMed ID: 309102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
    Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
    Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of small-cell carcinoma of the cervix with weekly combination chemotherapy.
    Tabbara IA; Grosh WA; Andersen WA; Taylor PT; Hahn SS; Stewart FM
    Eur J Cancer; 1990; 26(6):748-9. PubMed ID: 1697475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer.
    Torfs S; Cadron I; Amant F; Leunen K; Berteloot P; Vergote I
    Eur J Cancer; 2012 Jun; 48(9):1332-40. PubMed ID: 22317951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols].
    Jakse R; Scherlacher A; Lehnert M; Haas J
    HNO; 1986 Jun; 34(6):235-40. PubMed ID: 3744908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of advanced carcinoma of the cervix with adriamycin and methotrexate combined.
    Guthrie D; Way S
    Obstet Gynecol; 1974 Oct; 44(4):586-9. PubMed ID: 4547341
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
    Long HJ; Nelimark RA; Podratz KC; Suman V; Keeney GL; Nikcevich DA; Kugler JW; Rowland KM; Kardinal CG; Wos EJ
    Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer.
    Dowdy SC; Boardman CH; Wilson TO; Podratz KC; Hartmann LC; Long HJ
    Am J Obstet Gynecol; 2002 Jun; 186(6):1167-73. PubMed ID: 12066092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.